As 2019 draws to a close, the American Association for Cancer Research (AACR) is grateful for our growing ranks of cancer patients and survivors who join us in advocating for strong federal funding for medical research. This year, Tomma Hargraves and Nicole Robinson joined us on Capitol Hill for the Rally for Medical Research, an annual gathering in which more than 300 national organizations ask lawmakers to make continued funding for the National Institutes of Health a priority.Read More
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to experience a truly comprehensive training in breast cancer. During my tenure, I decided to take advantage of opportunities offered to me outside of the lab to learn about cancer from every angle, including attending weekly breast tumor boards and presenting my work to the Georgetown Breast Cancer Advocates (GBCA).
I’ll never forget at the end of my presentation with GBCA, one of the advocates, Jamie, asked what the side effects were for a new treatment I was proposing. I was proud that I had done some research on this and confidently stated, “they are the same as tamoxifen,” a commonly used breast cancer treatment.Read More
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the disease.
Neither did his local urologist in rural North Carolina.
Within three years, Lawing’s cancer metastasized. His local doctor referred him to a specialist in Charlotte. Under his care, Lawing began a clinical trial of an immunotherapeutic drug. His cancer stabilized. Over the past two decades, he has experienced several recurrences of cancer, but a steady stream of newly approved treatments, most recently the immunotherapeutic Opdivo (nivolumab), have kept his disease under control. He is currently monitored with quarterly CT scans, but is taking no additional medication and experiences no symptoms or side effects.Read More
The American Association for Cancer Research (AACR) is proud to support the Scientist↔Survivor Program (SSP), which provides cancer survivors with opportunities to engage in cancer research, survivorship issues, advocacy, and …Read More
Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend and learn from researchers at the AACR Annual Meeting, have put together some tips to help guide advocates who are attending this or any large scientific conference.Read More
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission to prevent and cure all cancer. News stories have featured scientific research, interviews with AACR leadership, and a first-person account of cancer’s financial toll.Read More
As spring is a time for flowers to bloom, public education at the American Association for Cancer Research (AACR) has also blossomed these past few months.
During the AACR Annual Meeting …
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to Washington, D.C., to address research challenges in cancer. But significant findings also came from cancer patient advocates and survivors who attended the meeting.Read More
A young adult shares his story of leaving college and learning to rely on his mother as he battled leukemia.Read More
The AACR is a founder and organizing partner of the Rally for Medical Research, which took place for the fourth consecutive year on September 22, bringing representatives of 300 organizations together in Washington, D.C., to advocate for continued funding for the National Institutes of Health (NIH).Read More